RENASANT CORP
For the period ended Mar 31, 2025. Filed May 8, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 8, 2025
RNST$39.39-0.8%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Changes in Shareholders’ Equity
(Unaudited)
| Common Stock · Treasury Stock · Additional Paid-In Capital · Retained Earnings · Accumulated Other Comprehensive Income (Loss) · Total | |||||||
|---|---|---|---|---|---|---|---|
| Three Months Ended March 31, 2025 · Shares · Amount | |||||||
| Balance at January 1, 2025 | 63,565,690 | $332,421 | $(97,196) | $1,491,847 | $1,093,854 | $(142,608) | $2,678,318 |
| Net income | — | — | — | — | 41,518 | — | 41,518 |
| Other comprehensive income | — | — | — | — | — | 20,987 | 20,987 |
| Comprehensive income | 62,505 | ||||||
| Cash dividends ($0.22 per share) | — | — | — | — | (14,270) | — | (14,270) |
| Issuance of common stock for stock-based compensation awards | 173,777 | — | 5,550 | (8,778) | — | — | (3,228) |
| Stock-based compensation expense | — | — | — | 3,780 | — | — | 3,780 |
| Balance at March 31, 2025 | 63,739,467 | $332,421 | $(91,646) | $1,486,849 | $1,121,102 | $(121,621) | $2,727,105 |
| Common Stock · Treasury Stock · Additional Paid-In Capital · Retained Earnings · Accumulated Other Comprehensive Income (Loss) · Total | |||||||
|---|---|---|---|---|---|---|---|
| Three Months Ended March 31, 2024 · Shares · Amount | |||||||
| Balance at January 1, 2024 | 56,142,207 | $296,483 | $(105,249) | $1,308,281 | $952,124 | $(154,256) | $2,297,383 |
| Net income | — | — | — | — | 39,409 | — | 39,409 |
| Other comprehensive loss | — | — | — | — | — | (2,687) | (2,687) |
| Comprehensive income | 36,722 | ||||||
| Cash dividends ($0.22 per share) | — | — | — | — | (12,653) | — | (12,653) |
| Issuance of common stock for stock-based compensation awards | 162,653 | — | 5,566 | (8,660) | — | — | (3,094) |
| Stock-based compensation expense | — | — | — | 3,992 | — | — | 3,992 |
| Balance at March 31, 2024 | 56,304,860 | $296,483 | $(99,683) | $1,303,613 | $978,880 | $(156,943) | $2,322,350 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.